GlassScriptPhysician profile
David Charles Graham
NPI 1215291562
$2,209.07
in general payments reported to CMS, 2019-2025
12 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $42.87 · 2021: $220 · 2022: $1,376 · 2023: $145 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,067.13 | 2022 | |
| Smith+Nephew, INC. | $361.20 | 2021-2022 | |
| Stryker Corporation | $232.43 | 2019-2025 | Citrefix |
| Integra Lifesciences Corporation | $188.29 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Extremity Medical | $135.77 | 2022 | |
| Depuy Synthes Sales INC. | $92.00 | 2025 | Hammerlock, Na |
| Wright Medical Technology, INC. | $29.24 | 2019 | |
| Bioventus LLC | $28.68 | 2025 | Exogen Ultrasound Bone Healing System |
| Sandoz INC. | $24.43 | 2025 | Wyost, Jubbonti |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.09 | 2025 | Jublia |
| Tandem Diabetes Care, INC. | $17.07 | 2021 | |
| Horizon Therapeutics Plc | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.